Comprehensive ADC And Bioconjugation Services For Targeted Therapies

Discover a trusted CDMO partner with more than 15 years of industry-leading experience in conjugation and purpose-built manufacturing facilities. MilliporeSigma offers end-to-end services to bring your ADCs and bioconjugates into the clinic and to commercialization, employing a collaborative approach and ensuring a reliable supply chain for the development, manufacturing, and testing of bulk drug substance (BDS) and drug product (DP).

Equipped with the expertise to develop and manufacture your bioconjugate or ADC, MilliporeSigma has handled over 100 constructs, 1000 development batches, 60 INDs, and 240 GMP batches (including 25 for commercial use). Continue reading to learn more about these comprehensive ADC and bioconjugation solutions.